Report
Kevin Huang

Boston Scientific Corporation

Underlying
Boston Scientific Corp.

Boston Scientific is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical fields. The company's businesses include: Endoscopy, which develops and manufactures devices to diagnose and treat gastrointestinal and pulmonary conditions; Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions; Cardiac Rhythm Management, which develops and manufactures implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; and Neuromodulation, which develops and manufactures devices to treat various neurological movement disorders and manage chronic pain.

Provider
CFRA Research
CFRA Research

As one of the world's leading independent research firms, CFRA provides differentiated and actionable analysis for our global subscribers to improve their investment and business decision-making.

 

Founded in 1994, CFRA consistently identifies actionable opportunities from which clients can gain an investment edge and avoid risk. Through a differentiated proprietary methodology blending forensic accounting and fundamental equity research, CFRA empowers sophisticated investment professionals, advisers and risk managers to uniquely analyze industries, funds and companies of their interest. CFRA’s global subscribers include the world’s leading institutional investors, wealth advisors, corporations, academics and governments. 

 On October 1, 2016, CFRA acquired S&P Global’s Equity and Fund Research business, a leading provider of independent research and commentary with offerings focused on stocks, ETFs and mutual funds as well as sectors and industries. The Equity and Fund Research business originated in the 1920’s and has amassed a worldwide base of investing clients. 

 The combined firm is committed to being the world's leading independent investment research firm with 75 global analysts, authoring in-depth qualitative research on 1,500+ companies. In addition, CFRA offers a comprehensive view on global sector themes, industries, and funds, through in-depth qualitative research on 11 Sectors, 42 Industries, 1,860+ ETFs, 22,000+ Mutual Funds, as well as quantitative company research on 20,000+ global companies. 

 Founded as the “Center for Financial Research and Analysis” in 1994, today our company is simply known as CFRA. However, our mission remains to be the “center” for our global clients by providing independent, differentiated and actionable analysis to help you make better investment and business decisions.

 

Analysts
Kevin Huang

Other Reports on these Companies
Other Reports from CFRA Research
Michael Gordon ...
  • Nicholas Rodelli
Michael Gordon ...
  • Nicholas Rodelli
Louise Cheung ...
  • Veronica Mercier
Other Reports from these Analysts
Kevin Huang
Kevin Huang
Kevin Huang

ResearchPool Subscriptions

Get the most out of your insights

Get in touch